Fig. 1: Weight loss and measures of appetite regulation in patients with primary weight loss failure (LowEBMIL group, orange) and patients with successful weight loss (HighEBMIL group, green) after Roux-en-Y gastric bypass. | International Journal of Obesity

Fig. 1: Weight loss and measures of appetite regulation in patients with primary weight loss failure (LowEBMIL group, orange) and patients with successful weight loss (HighEBMIL group, green) after Roux-en-Y gastric bypass.

From: Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake

Fig. 1

A Postoperative body mass index (BMI) (mean ± sem). B Plasma total GLP-1 (mean ± sem). C Plasma total PYY (mean ± sem). D Plasma active ghrelin (mean ± sem). E Relative effect (%) of octreotide versus placebo on ad libitum food intake at lunch (mean [95CI]). F Plasma CCK (mean ± sem). G Visual analogue scale (VAS) scores of satiety (median, 40–60 percentiles). H Visual analogue scale (VAS) scores of hunger (median, 40–60 percentiles). In panels (B–D) and (F–H), solid lines represent responses on the placebo day, whereas dashed lines represent responses on the octreotide day after breakfast (ingested at t = 0 min) and ad libitum lunch meal (ingested at t = 240 min).

Back to article page